Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Rational Design of Orthogonal Multipolar Interactions with Fluorine in Protein–Ligand Complexes

Journal Article · · Journal of Medicinal Chemistry
 [1];  [1];  [1];  [1];  [2];  [1];  [1]
  1. Univ. of Michigan, Ann Arbor, MI (United States). Dept. of Pathology
  2. Wroclaw Univ. of Technology (Poland). Dept. of Chemistry

Multipolar interactions involving fluorine and the protein backbone have been frequently observed in protein–ligand complexes. Such fluorine–backbone interactions may substantially contribute to the high affinity of small molecule inhibitors. Here we found that introduction of trifluoromethyl groups into two different sites in the thienopyrimidine class of menin–MLL inhibitors considerably improved their inhibitory activity. In both cases, trifluoromethyl groups are engaged in short interactions with the backbone of menin. In order to understand the effect of fluorine, we synthesized a series of analogues by systematically changing the number of fluorine atoms, and we determined high-resolution crystal structures of the complexes with menin. Here, we found that introduction of fluorine at favorable geometry for interactions with backbone carbonyls may improve the activity of menin–MLL inhibitors as much as 5- to 10-fold. In order to facilitate the design of multipolar fluorine–backbone interactions in protein–ligand complexes, we developed a computational algorithm named FMAP, which calculates fluorophilic sites in proximity to the protein backbone. We demonstrated that FMAP could be used to rationalize improvement in the activity of known protein inhibitors upon introduction of fluorine. Furthermore, FMAP may also represent a valuable tool for designing new fluorine substitutions and support ligand optimization in drug discovery projects. Analysis of the menin–MLL inhibitor complexes revealed that the backbone in secondary structures is particularly accessible to the interactions with fluorine. Lastly, considering that secondary structure elements are frequently exposed at protein interfaces, we postulate that multipolar fluorine–backbone interactions may represent a particularly attractive approach to improve inhibitors of protein–protein interactions.

Research Organization:
Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Organization:
USDOE Office of Science (SC)
Grant/Contract Number:
AC02-06CH11357
OSTI ID:
1222005
Journal Information:
Journal of Medicinal Chemistry, Journal Name: Journal of Medicinal Chemistry Journal Issue: 18 Vol. 58; ISSN 0022-2623
Publisher:
American Chemical Society (ACS)Copyright Statement
Country of Publication:
United States
Language:
ENGLISH

References (48)

A Fluorine Scan of Thrombin Inhibitors to Map the Fluorophilicity/Fluorophobicity of an Enzyme Active Site: Evidence for CF⋅⋅⋅CO Interactions journal June 2003
Fluorine Interactions at the Thrombin Active Site: Protein Backbone Fragments HCαCO Comprise a Favorable CF Environment and Interactions of CF with Electrophiles journal April 2004
Fluorine in Medicinal Chemistry journal April 2004
Organic Fluorine Hardly Ever Accepts Hydrogen Bonds journal January 1997
The Polar Hydrophobicity of Fluorinated Compounds journal July 2004
Inside Cover: Tailoring Small Molecules for an Allosteric Site on Procaspase-6 (ChemMedChem 1/2014) journal December 2013
Combined use of computational chemistry, NMR screening, and X-ray crystallography for identification and characterization of fluorophilic protein environments journal November 2010
Peptide-mediated interactions in biological systems: new discoveries and applications journal August 2008
Protein–protein interaction through β-strand addition journal August 2006
Potent, Highly Selective, and Orally Bioavailable Gem -Difluorinated Monocationic Inhibitors of Neuronal Nitric Oxide Synthase journal October 2010
Computational Discovery of Picomolar Q o Site Inhibitors of Cytochrome bc 1 Complex journal June 2012
Design and NMR-Based Screening of LEF, a Library of Chemical Fragments with Different Local Environment of Fluorine journal August 2009
(2 R )-4-Oxo-4-[3-(Trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3- a ]pyrazin- 7(8 H )-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine:  A Potent, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes journal January 2005
A Medicinal Chemist’s Guide to Molecular Interactions journal July 2010
Structure-Based Design of High-Affinity Macrocyclic Peptidomimetics to Block the Menin-Mixed Lineage Leukemia 1 (MLL1) Protein–Protein Interaction journal January 2013
Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemia journal January 2012
Author Correction: Structure of the yeast Swi/Snf complex in a nucleosome free state journal November 2020
Targeted editing and evolution of engineered ribosomes in vivo by filtered editing journal January 2022
Fluorine in medicinal chemistry journal January 2008
Assessment of helical interfaces in protein–protein interactions journal January 2009
PDB file parser and structure class implemented in Python journal November 2003
Coot model-building tools for molecular graphics journal November 2004
Automated and accurate deposition of structures solved by X-ray diffraction to the Protein Data Bank journal September 2004
The CCP4 suite programs for protein crystallography journal September 1994
Refinement of Macromolecular Structures by the Maximum-Likelihood Method journal May 1997
Fluorine in Pharmaceuticals: Looking Beyond Intuition journal September 2007
Structural insights into inhibition of the bivalent menin-MLL interaction by small molecules in leukemia journal November 2012
Orthogonal Multipolar Interactions in Structural Chemistry and Biology journal February 2005
The Polar Hydrophobicity of Fluorinated Compounds journal April 2004
[20] Processing of X-ray diffraction data collected in oscillation mode book January 1997
Hit-to-lead optimization and kinase selectivity of imidazo[1,2-a]quinoxalin-4-amine derived JNK1 inhibitors journal September 2013
Features of protein–protein interactions that translate into potent inhibitors: topology, surface area and affinity journal March 2012
Design, Synthesis, and Crystal Structure of Selective 2-Pyridone Tissue Factor VIIa Inhibitors journal September 2003
Structure-Based Design, Synthesis, and Characterization of Dual Hotspot Small-Molecule HIV-1 Entry Inhibitors journal April 2012
High-Affinity Small-Molecule Inhibitors of the Menin-Mixed Lineage Leukemia (MLL) Interaction Closely Mimic a Natural Protein–Protein Interaction journal February 2014
Physical Nature of Fatty Acid Amide Hydrolase Interactions with Its Inhibitors: Testing a Simple Nonempirical Scoring Model journal December 2014
Fluorine in medicinal chemistry journal January 2008
Fragment-guided design of subnanomolar  -lactamase inhibitors active in vivo journal October 2012
Molecular Basis of the Mixed Lineage Leukemia-Menin Interaction: IMPLICATIONS FOR TARGETING MIXED LINEAGE LEUKEMIAS journal October 2010
The calculation of small molecular interactions by the differences of separate total energies. Some procedures with reduced errors journal October 1970
Biopython: freely available Python tools for computational molecular biology and bioinformatics journal March 2009
MolProbity: all-atom contacts and structure validation for proteins and nucleic acids journal May 2007
TLSMD web server for the generation of multi-group TLS models journal January 2006
Coot model-building tools for molecular graphics journal November 2004
Automated and accurate deposition of structures solved by X-ray diffraction to the Protein Data Bank journal September 2004
The CCP4 suite programs for protein crystallography journal September 1994
Refinement of Macromolecular Structures by the Maximum-Likelihood Method journal May 1997
Targeting protein-protein interactions in hematologic malignancies: still a challenge or a great opportunity for future therapies? journal December 2014

Cited By (11)

Structure and Energetics of Ligand–Fluorine Interactions with Galectin‐3 Backbone and Side‐Chain Amides: Insight into Solvation Effects and Multipolar Interactions journal July 2019
Harnessing Fluorine–Sulfur Contacts and Multipolar Interactions for the Design of p53 Mutant Y220C Rescue Drugs journal June 2016
Dissecting the Structure–Activity Relationship of Galectin–Ligand Interactions journal January 2018
Taking Advantage of Hydrophobic Fluorine Interactions for Self-Assembled Quantum Dots as a Delivery Platform for Enzymes journal March 2018
Regulation of Protein Activity and Cellular Functions Mediated by Molecularly Evolved Nucleic Acids journal January 2019
Taking Advantage of Hydrophobic Fluorine Interactions for Self-Assembled Quantum Dots as a Delivery Platform for Enzymes journal March 2018
Regulation of Protein Activity and Cellular Functions Mediated by Molecularly Evolved Nucleic Acids journal January 2019
Are fluorine-based contacts predictable? A case study in three similar coordination compounds journal January 2017
A systematic analysis of atomic protein–ligand interactions in the PDB journal January 2017
Using Structural Analysis In Silico to Assess the Impact of Missense Variants in MEN1 journal September 2019
Study of Fluorinated Quantum Dots-Protein Interactions at the Oil/Water Interface by Interfacial Surface Tension Changes journal May 2018

Similar Records

Complexity of Blocking Bivalent Protein–Protein Interactions: Development of a Highly Potent Inhibitor of the Menin–Mixed-Lineage Leukemia Interaction
Journal Article · Tue May 08 00:00:00 EDT 2018 · Journal of Medicinal Chemistry · OSTI ID:1544860

Property Focused Structure-Based Optimization of Small Molecule Inhibitors of the Protein–Protein Interaction between Menin and Mixed Lineage Leukemia (MLL)
Journal Article · Sun Jan 24 23:00:00 EST 2016 · Journal of Medicinal Chemistry · OSTI ID:1498394

Structure-Based Discovery of M-89 as a Highly Potent Inhibitor of the Menin-Mixed Lineage Leukemia (Menin-MLL) Protein–Protein Interaction
Journal Article · Sat Jun 22 00:00:00 EDT 2019 · Journal of Medicinal Chemistry · OSTI ID:1544865